DRUGS MADE IN AMERICA ACQ II CORP
Price chart
Anonymous reader poll. Unscientific, not investment advice.
✦ StockVane Quant Insights how this is computed
- Mid-pack momentum — held if you own it, not a fresh buy.
- Signal has read HOLD for 1 year.
- Recent price momentum is +0.9% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Price is above its 20-day average and above its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 2848 U.S. stocks StockVane covers.
Last computed: 2026-11-22 14:27 UTC
Data coverage: 4 of 6 factors. Missing data is not a zero score.
The radar needs all six factors. Available grades are shown below.
Valuation C-
How expensive the stock is versus earnings, sales and its own 5-year history.
| P/E (TTM) | 27.6x | Better than 26% |
| P/E vs own 5-yr range | 65th pctl | Better than 44% |
Growth N/A
How fast revenue, profit and free cash flow are compounding.
Not enough data to grade this factor.
Profitability C-
How much profit the business keeps from each dollar of sales and capital.
| Return on equity | 1.7% | Better than 30% |
| Return on invested capital | 0.2% | Better than 29% |
Momentum A
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | 0.9% | Better than 76% |
| 6-month return | 1.7% | Better than 59% |
| Distance below 52-week high | 1.0% | Better than 99% |
Financial Health F
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 0.1x | Better than 0% |
| Debt to assets | 181.1% | Better than 0% |
Analyst View N/A
What the Street thinks: share of Buy ratings and upside to the average target.
Not enough data to grade this factor.
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.
Performance
Key statistics
Price & volume
- Prev close
- 10.25
- Open
- 10.24
- Day range
- 10.23 - 10.24
- Avg price
- 10.23
- Volume
- 486.89K
- Turnover
- 4.98M
- Turnover ratei
- 0.90%
- Volume ratioi
- 2.99
- Amplitudei
- 0.10%
- 52-week rangei
- 9.86 - 10.33
Valuation
- P/Ei
- 68.20
- P/E (TTM)i
- 27.65
- P/Bi
- 1.30
- EPSi
- 0.15
- Book value / shi
- 7.86
- Net profit
- 9.56M
- Net assets
- 500.55M
Share structure
- Market cap
- 651.65M
- Float capi
- 552.51M
- Shares out
- 63.70M
- Float sharesi
- 54.01M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- --
1.0% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-38.58M net over the window
Short interest
- Shares short
- 96.99K
- % of floati
- 0.15%
- Days to coveri
- 1.00
- As of
- 2026-10-30
Frequently asked questions
What is the current stock price of DRUGS MADE IN AMERICA ACQ II CORP (DMII)?
DRUGS MADE IN AMERICA ACQ II CORP last traded at 10.23. This page shows a periodic quote snapshot. Check the displayed quote time.
What is DRUGS MADE IN AMERICA ACQ II CORP's market cap?
About 651.65M.
What is the P/E ratio of DRUGS MADE IN AMERICA ACQ II CORP?
The trailing twelve-month P/E is 27.65, below its own 5-year average of 41.87 — in the middle of its historical range (64.58% percentile). See the Valuation tab for the full history.
Does DRUGS MADE IN AMERICA ACQ II CORP pay a dividend?
DRUGS MADE IN AMERICA ACQ II CORP does not currently pay a regular dividend.
What is DRUGS MADE IN AMERICA ACQ II CORP's StockVane Quant Rating?
The StockVane Momentum strategy currently rates DRUGS MADE IN AMERICA ACQ II CORP a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.
Quote time 2026-11-20 16:04:04 · For reference only, not investment advice and not tailored to your situation.
DRUGS MADE IN AMERICA ACQ II CORP discussion 0 comments